<DOC>
	<DOC>NCT00319605</DOC>
	<brief_summary>Phase IV, observational, post-authorization, cross sectional, open-label, multicenter study to evaluate the acceptability of oral solution of levetiracetam in patients with partial epilepsy as assessed by a questionnaire.</brief_summary>
	<brief_title>Cross Sectional Study to Evaluate the Acceptability of Oral Solution of Levetiracetam</brief_title>
	<detailed_description />
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Piracetam</mesh_term>
	<criteria>Patients 16 years old or older diagnosed with partial epilepsy with or without generalization receiving levetiracetam oral solution for at least 28 days before the study Patients with disturbances of the sense of taste and smell that can interfere with the assessment of the parameters of the study</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Cross sectional study</keyword>
	<keyword>acceptability</keyword>
	<keyword>levetiracetam</keyword>
	<keyword>oral solution</keyword>
	<keyword>Keppra</keyword>
</DOC>